Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Liver Cirrhosis × epigallocatechin gallate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis 1 Leiomyoma 1 Inflammation 1 Frailty 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Carcinoma, Hepatocellular 1

Interventions

tremelimumab 1 epigallocatechin gallate 1 durvalumab 1 Ultrasonography 1 Everolimus 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06015022 2025-09-05

CATCH-B

University of Texas Southwestern Medical Center

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡